Regeneron Pharmaceuticals (REGN) EV to EBITDA (2012 - 2026)
Regeneron Pharmaceuticals' EV to EBITDA came in at 12.83 for Q2 2026, up 17.0% from 10.96 a year earlier but down 25.3% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EV to EBITDA (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported EV to EBITDA of 6.93, up 46.8% year-over-year; for FY2025, it was 17.50, up 15.4% from FY2024.
- Going back by year, EV to EBITDA was 15.17 in FY2024 (-18.2%), 18.55 in FY2023 (+35.5%), 13.69 in FY2022 (+70.8%) and 8.02 in FY2021 (-44.6%).
- The five-year range for quarterly EV to EBITDA is 8.02 (Q4 2021) to 23.82 (Q2 2024).
- Year-over-year, EV to EBITDA has increased for three consecutive quarters, with an average decline of 7.7% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in Q1 2023 (growth of 88.6%), and the weakest in Q2 2025 (a decline of 54.0%).
- Business Quant data shows REGN's EV to EBITDA at 17.17 (Q1 2026), 17.50 (Q4 2025) and 11.82 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.83 |
| Mar 31, 2026 | 17.17 |
| Dec 31, 2025 | 17.50 |
| Sep 30, 2025 | 11.82 |
| Jun 30, 2025 | 10.96 |
| Mar 31, 2025 | 13.71 |
| Dec 31, 2024 | 15.17 |
| Sep 30, 2024 | 23.37 |
| Jun 30, 2024 | 23.82 |
| Mar 31, 2024 | 21.75 |
| Dec 31, 2023 | 18.55 |
| Sep 30, 2023 | 16.76 |
| Jun 30, 2023 | 14.37 |
| Mar 31, 2023 | 16.49 |
| Dec 31, 2022 | 13.69 |
| Sep 30, 2022 | 10.17 |
| Jun 30, 2022 | 9.55 |
| Mar 31, 2022 | 8.74 |
| Dec 31, 2021 | 8.02 |
| Sep 30, 2021 | 8.99 |
API Access
Regeneron Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();